PPT-Statin Adherence Purpose

Outline the issue of medication nonadherence and reasons that patients may not adhere to medications with a particular focus on statin Review strategies to improve patient adherence to statins 2. www.YourDiabetesInfo.org/MedicationAdherence. . Medication Adherence: Resources for Patients. Medication Adherence: Resources for Health Care Teams. Medication Adherence: Scientific Evidence. Criteria For Inclusion. Meck Chongo, . Virginia . Russell, . Josée. Lavoie, Ross Hoffman, . Mamdouh. . Shubair. University of Northern British Columbia. Agenda. . Background. Objectives . Participants & Research Environment. Bernard Vrijens, PhD. Chief Science Officer, MWV Healthcare. Associate Professor of Biostatistics . University of Liège, Belgium. Adherence is key to therapeutic success. 2. Effective. Disease. Management. Reasons why patients do not adhere. Measuring adherence and non adherence. Improving adherence. Reasons for non-adherence: cognitive rational non-adherence. Adherence is all about being conscientious in following medical advice. . Ronni. AW Wetmore, RN, MS. Coordinator, Stanford Adult Cystic Fibrosis Center. Speaker Bureau: . Chiesi. Pharmaceuticals. Nurse Advisory Board: Genentech Pharmaceutical Company. Nurse Advisory Board: Gilead Pharmaceutical. Canadian Consensus . Working Group Update (2016). G.B. John Mancini, MD, Steven Baker, MD, Jean Bergeron, MD, David Fitchett, MD, . Jiri Frohlich, MD, Jacques Genest, MD, Milan Gupta, MD, Robert A. Hegele, MD, . Reasons why patients do not adhere. Measuring adherence and non adherence. Improving adherence. Adherence is all about being conscientious in following medical advice. . This . section looks specifically at following recommendations for taking . Lessons from a 3-month Placebo Gel Trial at 3 US sites. Alex Carballo-Diéguez, Ph.D. .. Columbia University, NYC, US. Background. In the USA, young men who have sex with men (YMSM), especially those who are ethnic minorities, have high prevalence and incidence of HIV. Jessica Haberer, MD, MS. July . 24, . 2017. Conflicts of Interest. I have no conflicts to declare. Grant funding: US National Institutes of Health, Bill and Melinda Gates Foundation, USAID. Consultation: US National Institutes of Health, World Health Organization, Merck. Under-Representation of Women . in Clinical Trials. CVD in Women. Women. ’. s CV Risk is Often Misunderstood or Misdiagnosed. Gender Disparities in Screening, Diagnosis, and Treatment of Dyslipidemia. Thomas Delate, PhD, MS. Clinical Pharmacy Research Scientist. Kaiser Permanente Colorado. What to Expect Today. Review . biostatistic. . principles. Hands on application. Questions related to your research project. Diagnosis, Prevention and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016) G.B. John Mancini, MD, Steven Baker, MD, Jean Bergeron, MD, David Fitchett, MD, of the NLA. Conclusions of the NLA Safety Task Force for Muscle Safety. Myopathy and rhabdomyolysis are associated with statin therapy, as a class effect. Elevated creatine kinase (CK) levels may indicate statin-induced muscle damage. Slide deck. The full text of the paper is available at. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31652-0/fulltext. . Rationale. Lipoprotein. (a) . is. an . established. . risk.